Fondazione Telethon
19
3
5
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.3%
1 terminated/withdrawn out of 19 trials
90.9%
+4.4% vs industry average
16%
3 trials in Phase 3/4
40%
4 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies
Role: collaborator
Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant
Role: collaborator
A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome
Role: lead
Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD
Role: collaborator
Gene Therapy for Wiskott-Aldrich Syndrome
Role: lead
Natural History Study in Subjects With Usher Syndrome
Role: lead
Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk
Role: collaborator
Gene Therapy in Patients With Mucopolysaccharidosis Disease
Role: lead
Targeting the Gut to Improve Seizure Control in CDKL5 Deficiency Disorder (CDD)
Role: collaborator
Retroviral Insertion Site Methodology Study
Role: lead
ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID
Role: lead
Methodology Study of Retroviral Insertion Site Analysis in Strimvelis Gene Therapy
Role: lead
Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)
Role: lead
Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs)
Role: lead
Use of Phenylbutyrate Therapy for Patients With Pyruvate Dehydrogenase Complex Deficiency.
Role: lead
Gene Therapy for Transfusion Dependent Beta-thalassemia
Role: collaborator
Treatment of Low Bone Density in Cystic Fibrosis.
Role: collaborator
Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease
Role: collaborator
Gene Therapy for ADA-SCID
Role: collaborator
All 19 trials loaded